Two new cervical total disc replacement devices, the prodisc® C Vivo and prodisc® C Nova, have recently received certification and the CE marking in compliance with the EU Medical Device Regulation (MDR). This certification confirms that these devices meet the rigorous standards of quality, safety, and performance set forth by the European Union. The prodisc C Vivo and prodisc C Nova are now authorized for use in treating cervical disc degeneration, offering patients a higher level of care and innovation in the medical field.